Next Webcast October 6th: Pain targeting mechanisms

Four expert speakers discuss the latest advances from their companies: Algomedix, Cara Therapeutics, Myoscience and Nektar Therapeutics.

Like Comment

The demand for new therapeutic strategies for pain is high because established drugs have major limitations, including lack of efficacy for conditions such as neuropathic pain and the potential for abuse for opioids. In this webcast, several companies that are working to target unmet needs in pain management will present their developments, which include analgesics with novel mechanisms of action, opioids with reduced potential for abuse and medical devices.

The webcast will also include a round-table discussion and a Q&A section to allow you to hear direct expert opinions from the speakers and contribute your own thoughts.

Sign up now to watch this live or in your own time:

Go to the profile of Veronica Zacatenco

Veronica Zacatenco

Business Development Executive, Nature Publishing Group

Our team makes every effort to support the business development needs of the biopartnering community through our publications BioPharma Dealmakers, MedTech Dealmakers and our series of associated webcasts. I am interested in hearing about your partnering communication needs as well as your suggestions or comments.

No comments yet.